| Cancer, Hypoxia, and Metabolism | Lifetime | 37 | IT 1 | 99.83 |
| Mast cells and histamine | Lifetime | 8 | IT 1 | 99.73 |
| Angiogenesis and VEGF in Cancer | Lifetime | 19 | IT 1 | 99.79 |
| Proteoglycans and glycosaminoglycans research | Lifetime | 26 | IT 1 | 99.35 |
| Multiple Myeloma Research and Treatments | Lifetime | 53 | IT 3 | 99.60 |
| Lymphatic System and Diseases | Lifetime | 16 | IT 1 | 99.17 |
| Cell Adhesion Molecules Research | Lifetime | 111 | IT 2 | 99.52 |
| Cancer Cells and Metastasis | Lifetime | 104 | IT 3 | 99.44 |
| Fibroblast Growth Factor Research | Lifetime | 30 | IT 2 | 99.08 |
| Platelet Disorders and Treatments | Lifetime | 87 | IT 11 | 99.11 |
| Immune cells in cancer | Lifetime | 128 | IT 11 | 99.13 |
| Congenital heart defects research | Lifetime | 83 | IT 2 | 99.14 |
| Neuroblastoma Research and Treatments | Lifetime | 118 | IT 10 | 99.08 |
| Kruppel-like factors research | Lifetime | 39 | IT 7 | 98.94 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 90 | IT 11 | 98.84 |
| melanin and skin pigmentation | Lifetime | 80 | IT 4 | 98.77 |
| Chemokine receptors and signaling | Lifetime | 63 | IT 7 | 98.72 |
| Polyamine Metabolism and Applications | Lifetime | 96 | IT 4 | 98.26 |
| Axon Guidance and Neuronal Signaling | Lifetime | 65 | IT 2 | 98.67 |
| Histone Deacetylase Inhibitors Research | Lifetime | 178 | IT 8 | 98.13 |
| Apelin-related biomedical research | Lifetime | 64 | IT 2 | 97.52 |
| Erythropoietin and Anemia Treatment | Lifetime | 92 | IT 10 | 98.30 |
| Tissue Engineering and Regenerative Medicine | Lifetime | 420 | IT 13 | 97.74 |
| Cancer Research and Treatments | Lifetime | 566 | IT 11 | 97.18 |
| Barrier Structure and Function Studies | Lifetime | 125 | IT 3 | 96.89 |
| Protease and Inhibitor Mechanisms | Lifetime | 471 | IT 7 | 97.13 |
| Cancer, Lipids, and Metabolism | Lifetime | 835 | IT 28 | 97.11 |
| Ubiquitin and proteasome pathways | Lifetime | 840 | IT 12 | 96.70 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 445 | IT 16 | 96.67 |
| Zebrafish Biomedical Research Applications | Lifetime | 198 | IT 2 | 96.65 |
| Hippo pathway signaling and YAP/TAZ | Lifetime | 269 | IT 9 | 94.88 |
| Medical and Biological Sciences | Lifetime | 526 | IT 13 | 93.45 |
| Salivary Gland Disorders and Functions | Lifetime | 459 | IT 24 | 95.30 |
| Medical History and Innovations | Lifetime | 139 | IT 1 | 94.10 |
| Protein Degradation and Inhibitors | Lifetime | 823 | IT 40 | 94.70 |
| TGF-β signaling in diseases | Lifetime | 448 | IT 7 | 94.21 |
| Biomarkers in Disease Mechanisms | Lifetime | 295 | IT 41 | 90.79 |
| Vascular Tumors and Angiosarcomas | Lifetime | 593 | IT 46 | 93.41 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | Lifetime | 568 | IT 23 | 90.34 |
| History of Medicine Studies | Lifetime | 255 | IT 18 | 88.58 |
| Sympathectomy and Hyperhidrosis Treatments | Lifetime | 877 | IT 92 | 81.07 |
| Historical Medical Research and Treatments | Lifetime | 295 | IT 2 | 77.03 |
| Comparative Animal Anatomy Studies | Lifetime | 787 | IT 24 | 70.72 |
| Angiogenesis and VEGF in Cancer | 2021-2025 | 3 | IT 1 | 99.10 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 33 | IT 1 | 98.46 |
| Immune Cell Function and Interaction | 2021-2025 | 89 | IT 3 | 98.58 |
| Cancer Cells and Metastasis | 2021-2025 | 40 | IT 2 | 97.72 |
| Mast cells and histamine | 2021-2025 | 10 | IT 1 | 98.88 |
| Immune cells in cancer | 2021-2025 | 145 | IT 3 | 96.68 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 756 | IT 51 | 97.11 |
| Fibroblast Growth Factor Research | 2021-2025 | 56 | IT 4 | 91.00 |
| Lymphoma Diagnosis and Treatment | 2021-2025 | 671 | IT 42 | 94.41 |
| Congenital heart defects research | 2021-2025 | 359 | IT 14 | 83.66 |
| Cell Adhesion Molecules Research | 2021-2025 | 318 | IT 11 | 82.26 |
| Lymphatic System and Diseases | 2021-2025 | 312 | IT 22 | 80.79 |
| Axon Guidance and Neuronal Signaling | 2021-2025 | 94 | IT 9 | 74.54 |
| Salivary Gland Disorders and Functions | 2021-2025 | 531 | IT 60 | 77.78 |
| Polyamine Metabolism and Applications | 2021-2025 | 272 | IT 12 | 73.62 |
| Wnt/β-catenin signaling in development and cancer | 2021-2025 | 261 | IT 14 | 68.67 |
| Barrier Structure and Function Studies | 2021-2025 | 359 | IT 10 | 66.63 |
| Zebrafish Biomedical Research Applications | 2021-2025 | 669 | IT 34 | 65.53 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 550 | IT 59 | 52.82 |